Pharmacovigilance 2.0: The Impact of AI on Adverse Event Detection

The advent of artificial intelligence (AI) is ushering in a new era of pharmacovigilance, transforming how adverse events (AEs) are detected and managed across the pharmaceutical industry. Traditionally, pharmacovigilance has relied on manual reporting systems, where healthcare professionals and patients report adverse drug reactions (ADRs) to regulatory agencies and pharmaceutical companies. While effective, this approach has limitations, including delays in identifying safety signals, underreporting of ADRs, and the significant time and resources required to process and analyze reports. AI is revolutionizing this landscape by enhancing the speed, accuracy, and depth of adverse event detection, thereby creating a more robust and responsive pharmacovigilance framework.

1. Welcome Pharmacovigilance 2.0: The Impact of AI on Adverse Event Detection ZIYAUDDIN SAYYED QUALIFICATION : B.Pharm Student ID : 084/062024 28/06/2024 www.clinosol.com | follow us on social media @clinosolresearch 1

2. Index Introduction to Pharmacovigilance . Traditional Challenges in Pharmacovigilance . Evolution to Pharmacovigilance 2.0. How AI Enhances Adverse Event Detection. Benefits of AI in Pharmacovigilance. Challenges in Implementing AI in Pharmacovigilance. Real-Life Examples. Future Trends in AI-driven Pharmacovigilance. Conclusion. 28/06/2024 www.clinosol.com | follow us on social media @clinosolresearch 2

3. Introduction to Pharmacovigilance . Definition : Pharmacovigilance is the science of keeping patients safe from harmful effects of medications. It involves watching for and studying any unwanted side effects or problems that medicines might cause. The goal is to understand these effects, find ways to prevent them, and make sure that medicines are as safe as possible for everyone. Importance: Pharmacovigilance is crucial because it helps protect patients by spotting and managing the risks linked to medicines, making sure they are safe to use and beneficial for public health. 28/06/2024 www.clinosol.com | follow us on social media @clinosolresearch 3

4. Traditional Challenges in Pharmacovigilance Manual Reporting: Relies on manual reporting systems which can be time-consuming and prone to errors. Data Complexity: Handling diverse and large volumes of structured and unstructured data from various sources. Time Sensitivity: Delays in identifying and responding to adverse events due to the time-intensive nature of traditional methods. 28/06/2024 www.clinosol.com | follow us on social media @clinosolresearch 4

5. Evolution to Pharmacovigilance 2.0 Role of AI: AI technologies such as machine learning and natural language processing (NLP) automate and enhance adverse event detection and monitoring processes. Automated Signal Detection: AI enables continuous and automated detection of potential safety signals from diverse data streams including medical records, social media, and patient forums. Real-time Monitoring: Provides real-time surveillance and early detection of adverse events, facilitating timely interventions and risk mitigation strategies. 28/06/2024 www.clinosol.com | follow us on social media @clinosolresearch 5

6. How AI Enhances Adverse Event Detection Speed and Efficiency: AI algorithms can analyze vast amounts of data rapidly, significantly reducing the time required to detect and assess adverse events. Accuracy and Precision: AI enhances accuracy in identifying both common and rare adverse events, minimizing false positives and negatives. Scalability: AI systems are scalable and capable of handling increasing data volumes and complexity, ensuring robust pharmacovigilance capabilities as data sources expand. 28/06/2024 www.clinosol.com | follow us on social media @clinosolresearch 6

7. Benefits of AI in Pharmacovigilance. Early Detection: Enables early detection of safety signals, allowing for proactive risk management and mitigation strategies. Enhanced Safety Monitoring: Improves the overall quality and effectiveness of drug safety monitoring programs. Resource Optimization: Reduces manual workload and optimizes human resources, leading to cost savings and improved operational efficiency. 28/06/2024 www.clinosol.com | follow us on social media @clinosolresearch 7

8. Challenges in Implementing AI in Pharmacovigilance. Data Privacy and Security: Ensuring compliance with strict data protection regulations (e.g., GDPR, HIPAA) to safeguard patient confidentiality. Regulatory Compliance: Meeting regulatory requirements and standards for pharmacovigilance and adverse event reporting. Integration Complexity: Integrating AI systems with existing pharmacovigilance frameworks, databases, and IT infrastructure poses technical and operational challenges. 28/06/2024 www.clinosol.com | follow us on social media @clinosolresearch 8

9. Challenges in Implementing AI in Pharmacovigilance . 28/06/2024 www.clinosol.com | follow us on social media @clinosolresearch 9

10. Real-Life Examples: Case Study 1: AI algorithms identifying unexpected adverse events earlier than traditional methods during clinical trials, leading to improved patient safety outcomes. Case Study 2: Pharmaceutical companies leveraging AI to monitor social media and online forums for real-time adverse event reporting and patient feedback. 28/06/2024 www.clinosol.com | follow us on social media @clinosolresearch 10

11. Future Trends in AI-driven Pharmacovigilance. Predictive Analytics: Utilizing AI to predict potential adverse events based on historical data and predictive modeling. Global Collaboration: Facilitating global collaboration and data sharing of AI-driven insights to enhance drug safety monitoring and regulatory decision-making. Integration with EHRs: Integrating AI with Electronic Health Records (EHRs) to enhance data accuracy, completeness, and accessibility for comprehensive patient safety analysis. 28/06/2024 www.clinosol.com | follow us on social media @clinosolresearch 11

12. Conclusion: Impact of AI: AI is transforming pharmacovigilance by enhancing the speed, accuracy, and efficiency of adverse event detection and monitoring. Future Outlook: Continued advancements in AI technology will further revolutionize drug safety monitoring, improving patient outcomes and public health globally. 28/06/2024 www.clinosol.com | follow us on social media @clinosolresearch 12

13. Thank You! www.clinosol.com (India | Canada) 9121151622/623/624 [email protected] 28/06/2024 www.clinosol.com | follow us on social media @clinosolresearch 13